Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Change in Receivables (2021 - 2026)

MedWellAI has reported Change in Receivables over the past 6 years, most recently at -$287.0 for Q3 2025.

  • Quarterly Change in Receivables rose 76.08% to -$287.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$26899.0 through Dec 2025, down 211.97% year-over-year, with the annual reading at -$2588.0 for FY2025, N/A changed from the prior year.
  • Change in Receivables was -$287.0 for Q3 2025 at MedWellAI, up from -$132239.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $127826.0 in Q1 2021 and troughed at -$132239.0 in Q2 2025.
  • The 4-year median for Change in Receivables is $12468.5 (2024), against an average of $13516.7.
  • Year-over-year, Change in Receivables plummeted 164.98% in 2022 and then soared 76.08% in 2025.
  • A 4-year view of Change in Receivables shows it stood at -$81030.0 in 2021, then surged by 61.55% to -$31153.0 in 2022, then soared by 180.97% to $25224.0 in 2024, then tumbled by 101.14% to -$287.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Change in Receivables are -$287.0 (Q3 2025), -$132239.0 (Q2 2025), and $105627.0 (Q1 2025).